InvestorsHub Logo
Followers 12
Posts 2745
Boards Moderated 1
Alias Born 03/16/2005

Re: None

Wednesday, 04/24/2024 4:12:08 PM

Wednesday, April 24, 2024 4:12:08 PM

Post# of 768
Iovance will be presenting at the ASCO: "Oral Presentation of Updated Results of IOV-COM-202 Cohort 1A of Lifileucel plus Pembrolizumab in Advanced Frontline Melanoma"

https://ir.iovance.com/news-releases/news-release-details/iovance-biotherapeutics-present-clinical-and-translational-data
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IOVA News